157 related articles for article (PubMed ID: 4108984)
1. Subacute myelo-optic neuropathy in Australia.
Selby G
Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
[No Abstract] [Full Text] [Related]
2. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
Bron HL; Korten JJ; Pinckers AJ; Majoor CL
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
[No Abstract] [Full Text] [Related]
3. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
Selby G
Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
[No Abstract] [Full Text] [Related]
4. Subacute myelo-optico-neuropathy (SMON).
Nelson E
Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
[No Abstract] [Full Text] [Related]
5. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
[No Abstract] [Full Text] [Related]
6. [Case of subacute myelo-optico-neuropathy].
Mackiewicz J; Wendorff J
Neurol Neurochir Pol; 1980; 14(1):121-3. PubMed ID: 6445513
[TBL] [Abstract][Full Text] [Related]
7. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
Nakae K; Yamamoto S; Shigematsu I; Kono R
Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
[No Abstract] [Full Text] [Related]
8. S.M.O.N.
Spillane JD
Lancet; 1972 Jan; 1(7742):154. PubMed ID: 4109013
[No Abstract] [Full Text] [Related]
9. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
[No Abstract] [Full Text] [Related]
10. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
van Beeck JA; Scholten JB
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
[No Abstract] [Full Text] [Related]
11. Clioquinol: time to act.
de Pinto O; Burley D
Lancet; 1977 Jun; 1(8024):1256. PubMed ID: 68347
[No Abstract] [Full Text] [Related]
12. [Subacute myelo-optico neuropathy (author's transl)].
Heilig P; Thaler A
Klin Monbl Augenheilkd; 1974 Mar; 164(3):386-8. PubMed ID: 4277280
[No Abstract] [Full Text] [Related]
13. Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.
Meade TW
Br J Prev Soc Med; 1975 Sep; 29(3):157-69. PubMed ID: 127638
[TBL] [Abstract][Full Text] [Related]
14. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
[No Abstract] [Full Text] [Related]
15. [Subacute myelo-optic neuropathy--toxic reaction or viral disease?].
Dimov D
Lijec Vjesn; 1972 Jul; 94(7):363-6. PubMed ID: 4266549
[No Abstract] [Full Text] [Related]
16. [A iatrogenic disease... subacute myelo-optico-neuropathy].
Degos CF; Thomas-Lamotte PJ
Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
[No Abstract] [Full Text] [Related]
17. Neurotoxicity of clioquinol in laboratory animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117427
[No Abstract] [Full Text] [Related]
18. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
19. Myelopathy after clioquinol treatment.
Osterman PO
Lancet; 1971 Sep; 2(7723):544. PubMed ID: 4105685
[No Abstract] [Full Text] [Related]
20. [SMON (subacute myelo-optico-neuropathy)].
Kaeser HE
Schweiz Rundsch Med Prax; 1972 Jul; 61(29):927-30. PubMed ID: 4655587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
